This company’s drug could effectively end the HIV epidemic—but patients remember how it slow-walked a past treatment

Check out Charles Kenny and Justin Sandefur’s analysis with Nick Kristof on lives lost after USAID cuts, as featured in a Fast Company article about a new drug with the potential to end the HIV epidemic.